Thermo Fisher Webinars
-
Driving Measurable Productivity Gains In CHO Cell Culture
8/25/2026
Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.
-
Tackling Residual DNA Testing In Biotherapy Manufacturing
7/16/2025
Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.
-
Supply Resiliency For Bioprocessing Amid Global Volatility
10/2/2025
Build bioprocessing resiliency with strategic supply chain management. Learn to meet quality, compliance, and time-to-market demands amid global volatility with effective sourcing.
-
AAV Purification: Solving Downstream Challenges
6/9/2025
In this roundtable discussion, a trio of distinguished experts in AAV purification and process development share their expertise and best practices in tackling and solving downstream challenges.
-
Advancing The Purification Of VSV-G Pseudotyped Lentiviral Vector
6/9/2025
Discover new strategies to overcome lentiviral purification challenges with a scalable approach that maintains viral infectivity through gentle processing conditions.
-
The Role of Peptones In Enhancing Efficiency
9/30/2024
Discover how peptones enhance vaccine manufacturing efficiency with valuable insights into cost-effective solutions, variability control in biologically derived materials, and more.
-
The Way Forward: Supply Chain Solutions
10/24/2024
Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.
-
Manufacturing Considerations For Viral & Non-Viral Platform Selection
6/24/2025
In this webinar, a panel of experts spanning the lentiviral vector, exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.
-
Advancing Gene Therapy Development With A Multi-Serotype AAV Resin
5/29/2025
In this webinar, leading CDMO ABL and Thermo Fisher will share data on implementation of the POROS™ CaptureSelect™ AAVX affinity resin into such an AAV purification platform, including its performance in purifying several serotypes.
-
CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic
5/29/2026
As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.